These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 17112298

  • 21. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H, Mayer PR, Wajdula J, Fatenejad S.
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [Abstract] [Full Text] [Related]

  • 22. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.
    Faganel Kotnik B, Grabnar I, Bohanec Grabar P, Dolžan V, Jazbec J.
    Eur J Clin Pharmacol; 2011 Oct; 67(10):993-1006. PubMed ID: 21509569
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer.
    Bressolle F, Joulia JM, Pinguet F, Ychou M, Astre C, Duffour J, Gomeni R.
    Cancer Chemother Pharmacol; 1999 Oct; 44(4):295-302. PubMed ID: 10447576
    [Abstract] [Full Text] [Related]

  • 28. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
    Colom H, Farré R, Soy D, Peraire C, Cendros JM, Pardo N, Torrent M, Domenech J, Mangues MA.
    Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
    [Abstract] [Full Text] [Related]

  • 29. [Pharmacokinetics of methotrexate in children with acute lymphoblastic leukemia].
    Lares-Asseff I, Paredes R, Taboada C, Cravioto J, Velázquez M, Roldán RM, Faisal AG.
    Bol Med Hosp Infant Mex; 1988 Oct; 45(10):671-80. PubMed ID: 3264171
    [No Abstract] [Full Text] [Related]

  • 30. Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia.
    Hawwa AF, Collier PS, Millership JS, McCarthy A, Dempsey S, Cairns C, McElnay JC.
    Br J Clin Pharmacol; 2008 Dec; 66(6):826-37. PubMed ID: 18823306
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics and pharmacogenetics of high-dose methotrexate in Chinese adult patients with non-Hodgkin lymphoma: a population analysis.
    Yang L, Wu H, de Winter BCM, Sheng CC, Qiu HQ, Cheng Y, Chen J, Zhao QL, Huang J, Jiao Z, Xie RX.
    Cancer Chemother Pharmacol; 2020 May; 85(5):881-897. PubMed ID: 32246190
    [Abstract] [Full Text] [Related]

  • 32. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
    Etienne MC, Thyss A, Bertrand Y, Rubie H, Milano G.
    Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited.
    Sterba J, Dusek L, Demlova R, Valik D.
    Clin Chem; 2006 Apr; 52(4):692-700. PubMed ID: 16455868
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of Body Fat on Population Pharmacokinetics of High-Dose Methotrexate in Pediatric Patients With Acute Lymphoblastic Leukemia.
    Orgel E, Nabais T, Douglas C, Mittelman SD, Neely M.
    J Clin Pharmacol; 2021 Jun; 61(6):755-762. PubMed ID: 33314168
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients.
    Rodman JH, Sunderland M, Kavanagh RL, Ochs J, Yalowich J, Evans WE, Rivera GK.
    Cancer Res; 1990 Jul 15; 50(14):4267-71. PubMed ID: 2194652
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate.
    Ogungbenro K, Aarons L, CRESim & Epi-CRESim Project Groups.
    J Pharmacokinet Pharmacodyn; 2014 Apr 15; 41(2):173-85. PubMed ID: 24651962
    [Abstract] [Full Text] [Related]

  • 40. [Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia].
    Xu WQ, Tang YM, Fang CQ, Song H, Shi SW, Yang SL, Ren DT, Shen HQ, Qian BQ.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan 15; 26(1):15-8. PubMed ID: 15946502
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.